SELDI-TOF biomarker signatures for cystic fibrosis, asthma and chronic obstructive pulmonary disease

P. Gomes-Alves, M. Imrie, R. D. Gray, P. Nogueira, S. Ciordia, P. Pacheco, P. Azevedo, C. Lopes, A. B. de Almeida, M. Guardiano, D. J. Porteous, J. P. Albar, A. C. Boyd, D. Penque

Research output: Contribution to journalArticlepeer-review

Abstract

OBJECTIVES: The aim of this work was to establish protein profiles in serum and nasal epithelial cells of cystic fibrosis individuals in comparison with controls, asthma and chronic obstructive pulmonary disease patients for specific biomarker signatures identification. DESIGN AND METHODS: Protein extracts were analyzed by Surface Enhanced Laser Desorption/Ionization Time-Of-Flight Mass-Spectrometry (SELDI-TOF-MS). RESULTS: The mass spectra revealed a set of peaks with differential expression in serum and nasal cells among the different groups studied, resulting into peak signatures representative/specific of each pathology. Logistic regressions were applied to those peaks; sensitivity, specificity, Youden's indexes and area under the curve (AUC) of the respective receiver operating characteristic (ROC) curves were compared. DISCUSSION: Multivariate analysis demonstrated that combination of peaks has a better predictive value than the individual ones. These protein signatures may serve as diagnostic/prognostic markers for the studied diseases with common clinical features, or as follow-up assessment markers of therapeutic interventions.
Original languageEnglish
Pages (from-to)168-177
Number of pages10
JournalClinical Biochemistry
Volume43
Issue number1-2
DOIs
Publication statusPublished - 2010

Fingerprint Dive into the research topics of 'SELDI-TOF biomarker signatures for cystic fibrosis, asthma and chronic obstructive pulmonary disease'. Together they form a unique fingerprint.

Cite this